Pioneering the future of Dementia diagnostics
There is one new case of Dementia diagnosed every three seconds with an annual healthcare cost of the equivalent of one per cent of global GDP.
Smart Minds Dx
Effective prevention and treatment options for Alzheimer’s Disease, the leading cause of Dementia, are now available, but early and accurate diagnosis remains challenging.
Smart Minds Dx is transforming how Alzheimer’s Disease is detected, staged and monitored with scalable, accessible and affordable advanced diagnostics.
Proprietary detection antibodies, based on more than 40 years of research, drive the detection of blood-based biomarkers that will allow for earlier interventions for people with Alzheimer’s Disease neuropathological change.